The following comparison reveals that Rhythm360 is the only platform delivering comprehensive capabilities across four critical success factors: vendor-neutral CIED support, advanced AI triage, full EHR integration, and proven revenue impact. Competing platforms perform well in some areas but fall short when evaluated across all of these dimensions.
Platform | Vendor-Neutral CIED | AI Alert Triage | EHR Integration | Revenue Impact |
Rhythm360 | All OEMs | 80% faster response | Epic/Cerner/Athena | 300% increase |
PaceMate | Limited | Basic filtering | Select systems | Moderate |
Implicity | Multi-vendor | AI-powered | HL7 standard | Variable |
Murj | Partial | Workflow automation | Limited | Basic |
Rhythm360 delivers a comprehensive vendor-neutral platform for chronic cardiac disease management that unifies data from all major CIED manufacturers. It connects through advanced API integration, HL7 connectivity, and computer vision technology to bring device data into a single view.
The platform’s AI-powered alert triage system reduces critical response times by 80% while maintaining industry-leading data transmissibility across Medtronic, Abbott, Boston Scientific, and Biotronik devices. Clinicians see prioritized, clinically relevant alerts instead of overwhelming queues.
Bi-directional EHR integration with Epic, Cerner, and Athenahealth removes manual data entry and keeps records synchronized. Automated CPT billing then captures work that previously went unbilled, creating new revenue streams without adding staff.
A mid-sized cardiology practice using Rhythm360 tripled RPM revenue within six months. The team also identified weekend AFib episodes that triggered immediate anticoagulation therapy and helped prevent potential strokes.
The unified dashboard removed the need to log into multiple OEM portals and saved staff about 15 hours each week on administrative tasks.
PaceMate offers cloud-based CIED monitoring with workflow automation features tailored to electrophysiology practices. The platform supports basic alert filtering and report generation that can streamline routine follow-up work.
These strengths help practices with a narrow or single-vendor device mix. However, PaceMate lacks the fully vendor-neutral integration and advanced AI triage that define Rhythm360’s unified approach.
For practices that manage diverse device inventories, PaceMate’s limited multi-OEM capabilities can create data silos that Rhythm360 avoids through a single consolidated platform.
Implicity focuses on AI-driven remote monitoring for cardiac implantable devices and offers algorithmic alert filtering to reduce clinician workload. The French National Health Authority issued a favorable opinion in March 2026 for its remote monitoring of implantable cardiac monitors.
These capabilities support European programs that emphasize remote follow-up. However, Implicity’s more limited EHR integration options contrast with Rhythm360’s broad North American deployment and extensive connectivity with major EHRs.
Murj provides workflow automation for cardiac device monitoring with a focus on streamlining routine review tasks. It offers basic integration capabilities that help teams move away from manual spreadsheets and paper-based processes.
Murj does not match the advanced AI triage or comprehensive vendor-neutral data ingestion that define Rhythm360. Practices that require robust multi-OEM support often find Murj’s capabilities too narrow compared with Rhythm360’s unified platform.
Octagos emphasizes AI-driven filtering of non-actionable transmissions and supports bi-directional EHR integrations. Its algorithms target reduction of alert fatigue by screening routine device transmissions before they reach clinicians.
This focus improves signal-to-noise ratio for device alerts. Octagos, however, does not provide the broader chronic disease management capabilities that Rhythm360 offers for heart failure and hypertension RPM alongside rhythm management.
Rhythm Management Group combines a software platform with monitoring services, giving practices a hybrid model for cardiac device oversight. The platform includes workflow tools and optional outsourced clinical support.
This model can help smaller practices that lack internal staff capacity. Compared with Rhythm360’s advanced AI capabilities and documented revenue gains, the service-heavy approach can limit automation and long-term scalability.
Epic’s Cupid module embeds cardiac device monitoring inside the Epic EHR ecosystem. Practices already on Epic benefit from familiar workflows and seamless data flow within the same clinical record.
Cupid supports basic device data display and alert management but does not provide the specialized cardiac expertise or vendor-neutral capabilities that Rhythm360 delivers. Practices that manage multiple OEMs and want advanced AI-driven decision support often outgrow Cupid’s native tools.
Successful chronic cardiac disease management platforms must deliver specific capabilities that work together to address the complex needs of modern cardiology practices. The foundation is vendor-neutral data ingestion that unifies all device data into a single stream.
Heart failure prevalence is projected to rise from 2.45% to 3.60%, and atrial fibrillation from 1.58% to 2.31% by 2050. Platforms that lack these five capabilities will struggle to keep pace with growing clinical demand. See these five capabilities in action during a live walkthrough of the Rhythm360 platform.
Choosing the right chronic cardiac disease management platform works best when you align features with your practice size, patient mix, and financial goals. Use the following criteria as a structured checklist during vendor evaluations.
Practices that manage CIED patients alongside chronic heart failure and hypertension populations benefit from a single, comprehensive platform. Rhythm360 supports all of these service lines, removes the need for multiple vendors, and delivers both clinical and financial gains in one environment.
Vendor-neutral CIED management means a platform integrates data from all major cardiac device manufacturers, including Medtronic, Abbott, Boston Scientific, and Biotronik, into one interface. Clinical staff no longer need to log into separate OEM portals, which reduces administrative work and lowers the risk of missed critical events.
Effective heart failure RPM platforms combine CIED monitoring with tracking of physiological parameters through connected weight scales and blood pressure monitors. Rhythm360 supports this model by offering integrated service lines for rhythm disorders and chronic conditions in a single system.
This unified approach lets practices manage comprehensive cardiac care while capturing all eligible CPT codes across multiple programs.
RPM programs often generate substantial new revenue through accurate CPT billing and more efficient patient management. Studies report RPM returns of 22.2% or higher, with typical ROI of 3x to 5x and monthly reimbursement of $120 to $150 per patient.
Rhythm360 users have reported tripling RPM revenue through comprehensive billing automation and streamlined workflows that support higher patient volumes without proportional staffing increases.
Rhythm360 provides full vendor-neutral integration across all major CIED manufacturers, while PaceMate offers more limited multi-OEM support. Rhythm360’s AI-powered alert triage reduces response times by 80% and pairs with bi-directional Epic, Cerner, and Athenahealth integration.
In addition, Rhythm360’s documented revenue gains from automated CPT billing show stronger financial performance than PaceMate’s basic workflow tools.
Modern platforms should implement in four weeks or less, including EHR integration and staff training. Rhythm360’s onboarding process typically completes in a few days to a few weeks, depending on practice complexity and integration scope.
This rapid deployment helps practices realize clinical and financial benefits quickly without long disruptions to existing workflows.
Rhythm360 removes data silos, reduces alert fatigue, and closes revenue gaps for cardiology practices that manage multiple OEM portals and fragmented workflows. The platform delivers the alert response improvements and revenue gains described above while supporting scalable chronic cardiac disease management.
Experience how vendor-neutral CIED integration, AI-powered alert triage, and seamless EHR connectivity can transform your cardiac monitoring workflows and uncover missed revenue opportunities. Request your personalized platform walkthrough.
